Nevertheless, there was significantly lower activity of AMG 330 in relapsed/refractory AML specimens relative to newly diagnosed AML specimens despite similar expression levels of CD33 in these 2 specimen subsets in experiments in which healthy donor T-cells were added. The gene discussed is CD33; the disease is acute myeloid leukemia.